Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Capsule: SOP for Disintegration Testing of Hard Gelatin Capsules – V 2.0

Posted on By

Capsule: SOP for Disintegration Testing of Hard Gelatin Capsules – V 2.0

Standard Operating Procedure for Disintegration Testing of Hard Gelatin Capsules

Department Capsule Manufacturing
SOP No. SOP/CM/187/2025
Supersedes SOP/CM/187/2022
Page No. Page 1 of 8
Issue Date 01/02/2025
Effective Date 05/02/2025
Review Date 01/02/2026

1. Purpose

This SOP outlines the procedure for performing disintegration testing on hard gelatin capsules to ensure that the capsules meet the required disintegration specifications as per pharmacopoeial standards.

2. Scope

This SOP applies to the disintegration testing of all hard gelatin capsules to confirm that they disintegrate within the specified time frame under defined test conditions.

3. Responsibilities

  • Quality Control (QC) Team: Responsible for performing the disintegration testing on capsule samples and documenting the results.
  • Quality Assurance (QA) Team: Ensures that the disintegration testing is conducted according to the specified criteria and regulatory guidelines.
  • Production Team: Provides the required capsule samples for disintegration testing and ensures proper handling during the testing process.

4. Accountability

The QA Manager is accountable for ensuring the disintegration testing process complies with GMP and regulatory standards. The QC Supervisor oversees the execution of the testing process and ensures compliance. The Production Supervisor ensures that the appropriate

samples are provided for testing.

See also  Capsule: SOP for Screening Polymers for Capsule Coating - V 2.0

5. Procedure

5.1 Pre-Testing Setup

Before initiating disintegration testing, ensure the following:

  1. Review Testing Criteria

    1. Review the disintegration acceptance criteria for capsules based on the regulatory guidelines (e.g., USP, EP). These limits must be approved by the QA department before testing.
  2. Prepare Testing Equipment

    1. Ensure that the disintegration apparatus is calibrated according to the manufacturer’s specifications. Verify that the water bath temperature is maintained at 37°C ± 0.5°C.
  3. Prepare Sample Collection

    1. Collect a representative sample of capsules, typically 6 capsules, from the batch. The sample should be randomly selected to ensure it represents the entire batch.

5.2 Disintegration Testing Procedure

Follow these steps to perform the disintegration testing:

  1. Place Capsules in Disintegration Apparatus

    1. Place the capsules individually into the disintegration basket of the apparatus, ensuring that they are not touching each other or the sides of the basket.
  2. Initiate Testing

    1. Start the disintegration apparatus and ensure that the basket moves up and down in the medium (usually water at 37°C) at a consistent frequency (e.g., 30 cycles per minute) as per the specifications.
  3. Observe Disintegration

    1. Monitor the disintegration of the capsules and observe whether the capsule content completely disintegrates within the specified time, typically 30 minutes, as per the pharmacopoeial standards.
  4. Record Results

    1. Record the disintegration time for each capsule. If any capsule fails to disintegrate within the specified time, it is considered non-compliant.
See also  Capsule: SOP for Preformulation Studies for Capsule Dosage Forms - V 2.0

5.3 Post-Testing Activities

After the disintegration test is completed, ensure the following actions are performed:

  1. Review Results

    1. The QA Manager reviews the disintegration test results to ensure that the capsules meet the specified criteria. If any capsule fails to meet the criteria, initiate an investigation and determine the cause.
  2. Corrective Actions

    1. If a capsule fails the disintegration test, investigate the cause (e.g., formulation issues, capsule shell problems) and implement corrective actions, such as adjusting the formulation or production process.
  3. Training and Feedback

    1. If errors are identified in the testing process, provide feedback to operators and ensure proper training on the disintegration testing procedure.
  4. Record Keeping

    1. Ensure that all records related to disintegration testing, including the test logs, results, and corrective actions, are properly filed and archived according to regulatory and company requirements.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QA: Quality Assurance
  • QC: Quality Control
  • USP: United States Pharmacopeia
  • EP: European Pharmacopeia
  • pH: Potential Hydrogen (measure of acidity or alkalinity)
See also  Capsule: SOP for Stability Studies During Formulation Development - V 2.0

7. Documents

  1. Annexure 1: Equipment Calibration Log
  2. Annexure 2: Disintegration Testing Log
  3. Annexure 3: Corrective Action Report

8. References

  • USP <701> – Disintegration Test
  • European Pharmacopoeia 2.9.1 – Disintegration Test for Capsules
  • Good Manufacturing Practice (GMP) Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure 1: Equipment Calibration Log

Equipment ID Calibration Date Operator Calibration Details Next Calibration Due
Disintegration Apparatus 103 01/02/2025 John Doe Calibration of bath temperature and basket motion 01/02/2026

Annexure 2: Disintegration Testing Log

Capsule ID Test Date Disintegration Time (min) Acceptance Criteria Result Remarks
Batch 001 02/02/2025 12 Less than 30 minutes Pass No issues

Annexure 3: Corrective Action Report

Batch ID Deviation Corrective Action Responsible Person Completion Date
Batch 001 Capsule disintegration failure Adjusted capsule formulation and processing Production Supervisor 03/02/2025

12. Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial version of SOP Creation of SOP for disintegration testing QA Head
01/02/2025 2.0 Updated disintegration method and record format Improvement of testing and compliance QA Head
Capsules V 2.0 Tags:Active pharmaceutical ingredients (APIs) Capsule excipients, Capsule batch records, Capsule cleaning procedures, Capsule content uniformity, Capsule deviation management, Capsule disintegration testing, Capsule dissolution testing, Capsule filling process, Capsule inspection techniques, Capsule labeling requirements, Capsule maintenance protocols, Capsule Manufacturing, Capsule manufacturing equipment, Capsule packaging standards, Capsule process validation, Capsule production scheduling, Capsule Quality Control, Capsule regulatory compliance, Capsule safety guidelines, Capsule sealing methods, Capsule size specifications, Capsule stability testing, Capsule storage conditions, Capsule training programs, Empty capsule shells, Hard gelatin capsules, Pharmaceutical capsules, Soft gelatin capsules, Vegetarian capsules

Post navigation

Previous Post: Tablets: SOP for Final Inspection of Coated Tablets Before Packing – V 2.0
Next Post: Ointments: SOP for Cleaning and Re-Starting Manufacturing Lines – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version